Ashwagandha for Weight Loss: Does It Really Work?

Disclosure: This site may contain affiliate links. This content is for informational purposes only and does not constitute medical advice.

KEY TAKEAWAYS

• Ashwagandha is not a fat-burning supplement in the traditional sense — it works primarily by reducing cortisol and modulating the HPA axis, which indirectly supports weight management by addressing one of the most significant and least-treated drivers of abdominal fat accumulation in women over 40.
• A 2017 randomized, double-blind, placebo-controlled trial (Choudhary et al., Journal of Evidence-Based Complementary & Alternative Medicine) in 52 chronically stressed adults found meaningful reductions in perceived stress, food cravings, body weight, and BMI in the ashwagandha group — attributed primarily to cortisol reduction.
• A 2025 prospective RCT (Pakhale et al., Journal of Medicine and Life, PMC12863098) gave overweight adults KSM-66 at 300 mg twice daily for 24 weeks and found the ashwagandha group lost 8.46 kg versus 2.41 kg in the placebo group — a statistically significant result with a large effect size.
• A 2025 systematic review and meta-analysis (Bachour et al., PMC12242034) across 15 RCTs and 873 participants confirmed ashwagandha supplementation was associated with measurable reductions in cortisol, stress, and anxiety compared to placebo.
• Ashwagandha is most relevant for women whose weight gain is clearly stress- or cortisol-driven — belly fat that worsens under pressure, stress-eating patterns, and perimenopausal hormonal turbulence. Women whose weight challenges stem primarily from liver dysfunction, insulin resistance, or simple caloric surplus will find different ingredients more targeted.

The claims around ashwagandha and weight loss range from “ancient fat-burning herb” to “cortisol-busting miracle” — both of which overstate and mischaracterize what the research actually shows. The genuine case for ashwagandha in weight management is more specific and more nuanced than either extreme suggests, and understanding it precisely determines whether this ingredient is relevant to your situation.

Here’s what the science shows — and what it doesn’t.

What Ashwagandha Actually Is

Ashwagandha — botanical name Withania somnifera, from the nightshade family — has been used in Ayurvedic medicine for thousands of years. It is classified as an adaptogen: a compound that research suggests helps the body adapt to stress by modulating the hormonal and physiological stress response rather than directly stimulating or sedating it.

The primary active compounds are withanolides — steroidal lactones concentrated in the root — responsible for most of the documented research effects. Not all ashwagandha supplements are equivalent. Standardized root extracts — KSM-66 (standardized to at least 5% withanolides from root only) and Sensoril (10% withanolides from root and leaf) — appear most consistently in clinical research. Non-standardized root powder at equivalent total weights can deliver inconsistent active compound amounts, making the clinical trial findings harder to apply to unlabeled products.

The weight management relevance of ashwagandha flows through three mechanisms: cortisol regulation, thyroid function support, and muscle recovery — none of which are direct fat-burning pathways, but all of which address significant barriers to effective fat loss in women over 40.

The Cortisol Mechanism — Why It Matters More After 40

Cortisol — the primary stress hormone — promotes visceral fat accumulation through a direct receptor-density advantage: visceral adipose tissue has approximately four times the glucocorticoid receptor density of subcutaneous fat, meaning cortisol signals preferentially drive fat storage into the abdominal depot. It simultaneously suppresses fat oxidation, drives carbohydrate cravings as an energy-seeking stress response, promotes muscle catabolism that lowers resting metabolic rate, and impairs insulin signaling.

For women over 40 — where declining estrogen has already narrowed the hormonal buffer that modulates cortisol reactivity, where perimenopausal sleep disruption compounds HPA axis dysregulation, and where life stress often peaks — chronically elevated cortisol is one of the most significant and underaddressed mechanisms driving weight gain. Standard thermogenic fat burners don’t address this at all. Ashwagandha addresses it directly.

The evidence on cortisol reduction from standardized ashwagandha is among the most consistent in the adaptogen category.

A 60-day double-blind, randomized, placebo-controlled trial by Chandrasekhar et al. (PubMed PMID 23439798) gave 64 chronically stressed adults either 300 mg of KSM-66 or placebo. The ashwagandha group showed a statistically significant reduction in serum cortisol (p=0.0006) alongside improvements across all stress-assessment scales. The frequently cited 27.9% serum cortisol reduction comes from this study specifically.

A 2025 systematic review and meta-analysis (Bachour et al., published in BJPsych Open, PMC12242034) searched PubMed, Web of Science, Scopus, and Cochrane databases through September 2024 and included 15 randomized controlled trials with 873 participants. The review confirmed ashwagandha supplementation was associated with measurable reductions in cortisol, stress, and anxiety compared to placebo. The most consistent findings came from standardized root extracts taken at 300 to 600 mg per day for at least eight weeks.

A 2023 randomized, double-blind, placebo-controlled trial (Smith, Lopresti, Fairchild, Journal of Psychopharmacology, PubMed PMID 37740662) specifically enrolled overweight or mildly obese men and women aged 40 to 75 years — the most directly relevant population for this site — and gave them 200 mg of a standardized ashwagandha root extract (Witholytin®) twice daily for 12 weeks. This population-specific data point is notable: most ashwagandha trials recruit younger or mixed-age adults.

What the Weight Loss Data Actually Shows

With the mechanism established, the weight-specific evidence matters — and it is more direct than most ashwagandha articles acknowledge.

A 2017 randomized, double-blind, placebo-controlled trial by Choudhary, Bhattacharyya, and Joshi (Journal of Evidence-Based Complementary & Alternative Medicine) gave 52 chronically stressed, overweight adults either 300 mg of ashwagandha root extract twice daily or placebo for 8 weeks. The ashwagandha group showed statistically significant reductions in perceived stress, food cravings, body weight, and BMI compared to placebo. The mechanism was attributed primarily to cortisol reduction — the ashwagandha group had measurably lower serum cortisol at the end of the trial.

A more recent 2025 prospective randomized, double-blind, placebo-controlled study (Pakhale et al., Journal of Medicine and Life, PMC12863098) enrolled 100 overweight adults aged 19 to 65 and gave them either KSM-66 at 300 mg twice daily or placebo for 24 weeks. Primary endpoints were body weight and BMI. The ashwagandha group lost 8.46 kg versus 2.41 kg in the placebo group — a statistically significant result with a large effect size (Cohen’s d = 1.919). Secondary endpoints showed greater reductions in perceived stress, food cravings, and improvements in quality of life.

The honest read: ashwagandha does not produce dramatic thermogenic fat-burning effects. The weight loss observed in trials is driven by cortisol reduction, reduced stress-eating, and improved dietary adherence rather than by direct lipolysis. The effect is real and meaningful over 8 to 24 weeks — but it operates through an indirect mechanism that is specifically relevant for stress-driven weight gain, not as a general-purpose fat burner.

Thyroid Support — The Less-Discussed Mechanism

The connection between ashwagandha and thyroid function is relevant for women over 40, for whom subclinical thyroid slowdown is more common than in younger populations.

Research suggests ashwagandha may support thyroid hormone levels — specifically T3 and T4. Part of this effect may be indirect: cortisol impairs the conversion of T4 to the more metabolically active T3 form, so ashwagandha’s cortisol reduction may partially restore effective thyroid hormone availability regardless of any direct thyroid effect.

One RCT specifically examining ashwagandha in patients with subclinical hypothyroidism found meaningful improvements in both T3 and T4 at 8 weeks. For women with subclinical thyroid function contributing to metabolic sluggishness, this thyroid-supporting mechanism adds weight management relevance beyond the cortisol pathway alone. Women on prescribed thyroid medication should consult their healthcare provider before using ashwagandha due to potential interaction with thyroid hormone levels.

Muscle Recovery and Body Composition

A third mechanism — less commonly linked to weight loss but directly relevant for women using resistance training as their primary metabolic tool — is ashwagandha’s documented effect on muscle strength, recovery, and body composition.

Multiple controlled trials show ashwagandha supplementation producing meaningful improvements in muscle strength and recovery from exercise. One well-designed study found significantly greater muscle mass gains and fat mass reductions in ashwagandha-supplemented resistance trainers compared to placebo. The mechanism involves both modest testosterone support — ashwagandha shows this effect in both men and women across multiple studies — and cortisol reduction during recovery, since elevated cortisol during the recovery period impairs muscle protein synthesis.

For women over 40 using resistance training to maintain or rebuild the lean mass that governs resting metabolic rate, ashwagandha may amplify the metabolic benefit of that training directly.

the science of why muscle burns more energy than fat

Who Benefits Most — and Who Doesn’t

Based on its mechanisms, ashwagandha is most relevant for a specific profile:

Women with clearly cortisol-driven weight challenges are the primary candidates — those whose belly fat worsens during high-stress periods, whose eating patterns include significant stress-driven carbohydrate seeking, and whose cortisol-sleep-weight cycle is an identifiable pattern rather than a general caloric issue.

Women in perimenopause or early postmenopause experiencing hormonal turbulence that compounds cortisol reactivity — where estrogen’s buffer effect on the HPA axis is narrowing — may find ashwagandha’s cortisol regulation most specifically relevant.

Women with subclinical thyroid involvement in their metabolic slowdown may benefit from the thyroid-supporting mechanism alongside standard thyroid monitoring.

Women using resistance training as a metabolic cornerstone may find ashwagandha amplifies recovery and lean mass retention.

Women whose primary weight challenges stem from liver dysfunction, insulin resistance without a significant stress component, or straightforward caloric surplus are less specifically matched to ashwagandha’s mechanisms. The liver-function and AMPK-activation approach — through silymarin and berberine — addresses different upstream mechanisms entirely.

Practical Guidance: Dose, Form, and Timing

Dose: Most cortisol and weight management research uses 300 to 600 mg of standardized root extract per day, divided into one or two doses. The Pakhale 2025 trial used 300 mg twice daily (600 mg total). The Chandrasekhar 2012 trial used 300 mg once daily.

Form: Standardized extracts provide more consistent active compound delivery. KSM-66 (at least 5% withanolides, root-only) and Sensoril (10% withanolides, root and leaf) are the formats appearing most consistently in clinical research. Non-standardized root powder is less predictable.

Timing: Morning dosing aligns with the natural cortisol peak — the time when modulating the stress response is most relevant. Some users take a second dose in the evening for sleep support. Multi-ingredient formula timing follows the product instructions.

Cautions: Ashwagandha has uterine-stimulating properties in some research contexts and is not recommended during pregnancy. Women with hyperthyroidism or autoimmune thyroid conditions should consult a healthcare provider before use — the same thyroid-active properties that may benefit subclinical hypothyroidism could worsen hyperthyroid conditions. It may interact with thyroid medications, sedatives, and immunosuppressants.

FAQ

How long before ashwagandha produces noticeable effects?

Cortisol and stress measure reductions in controlled trials typically emerge at 4 to 6 weeks and are most significant at 8 to 12 weeks. The 2025 Pakhale trial ran 24 weeks and showed continued improvement across that timeline. Downstream weight management benefits — reduced stress eating, improved sleep, reduced belly fat accumulation rate — follow the cortisol timeline rather than producing immediate changes. Most users who report meaningful stress and appetite changes note these emerging between weeks four and eight.

Is ashwagandha a stimulant?

No — ashwagandha is essentially the opposite. Its mechanism calms the stress response system rather than activating it. Many users report improved sleep and reduced anxiety — experiences directly opposite to stimulant effects. This makes it specifically well-suited for perimenopausal women where stimulant sensitivity is increased and sleep quality already compromised. It supports metabolic health without adding to the stimulant burden.

Can I take ashwagandha with other supplements or medications?

Ashwagandha interacts with thyroid medications through its thyroid-active effects — women on levothyroxine or other thyroid drugs should discuss timing and dosing with a healthcare provider or pharmacist before starting. It may also interact with sedative medications and immunosuppressants. For women on any prescription medications, a quick check with a pharmacist is the appropriate first step.

Does ashwagandha work better for belly fat than for general weight?

Based on its cortisol mechanism, yes — in a specific sense. Visceral belly fat carries the highest glucocorticoid receptor density of any fat storage site, making it most responsive to cortisol-driven storage signals. Reducing cortisol through ashwagandha therefore preferentially reduces the hormonal signal most responsible for midsection fat accumulation specifically. This makes it more targeted for cortisol-driven belly fat than for general caloric weight management or fat in other locations.

Conclusion

Ashwagandha works — but it works through a specific mechanism that makes it highly relevant for some women and less relevant for others. For women whose weight gain is clearly stress- and cortisol-driven, the clinical evidence — including the 2025 Pakhale trial showing 8.46 kg lost versus 2.41 kg in placebo over 24 weeks — is more substantial than most supplement categories can claim.

For women whose metabolic difficulty is driven primarily by liver function decline, insulin resistance, or the hormonal shifts of menopause without a strong cortisol component, different mechanisms need to be addressed first. Understanding which driver is most active in your situation is the most important step — and it determines whether ashwagandha belongs at the center of your approach or as a supporting element alongside ingredients that target the upstream metabolic pathways.

liver-support supplements vs stimulant fat burners — what is the difference

References

1. Chandrasekhar K et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine. 2012. PubMed PMID 23439798. https://pubmed.ncbi.nlm.nih.gov/23439798/
2. Choudhary D, Bhattacharyya S, Joshi K. Body weight management in adults under chronic stress through treatment with ashwagandha root extract. Journal of Evidence-Based Complementary & Alternative Medicine. 2017. doi:10.1177/2156587216641830.
3. Smith SJ, Lopresti AL, Fairchild TJ. Exploring the efficacy and safety of Witholytin® ashwagandha root extract in overweight/obese adults aged 40–75 with stress and fatigue. Journal of Psychopharmacology. 2023. PubMed PMID 37740662. https://pubmed.ncbi.nlm.nih.gov/37740662/
4. Pakhale K et al. Efficacy and safety of Ashwagandha root extract on stress and weight management in adults. Journal of Medicine and Life. 2025. PMC12863098. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863098/
5. Bachour G et al. Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: Systematic Review and Meta-Analysis. BJPsych Open. 2025. PMC12242034. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242034/
6. Majeed M et al. A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life by modulating stress hormones: randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2023. PubMed PMID 37832082. https://pubmed.ncbi.nlm.nih.gov/37832082/

About the Author

Diana Woods is a health content researcher and writer specializing in women’s metabolic health, supplementation, and evidence-based nutrition. Her work focuses on translating peer-reviewed research into honest, practical content for women navigating midlife health. Diana is not a licensed clinician and does not provide medical advice.